In its upcoming report, Privia Health (PRVA) is predicted by Wall Street analysts to post quarterly earnings of $0.04 per share, reflecting an increase of 33.3% compared to the same period last year. Revenues are forecasted to be $520.06 million, representing a year-over-year increase of 12.8%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Privia Health metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Practice Collections' will reach $889.58 million. Compared to the current estimate, the company reported $792.50 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Care Margin' of $112.77 million. The estimate is in contrast to the year-ago figure of $107.70 million.
The consensus estimate for 'Platform Contribution' stands at $54.70 million. The estimate is in contrast to the year-ago figure of $53.20 million.
The average prediction of analysts places 'Implemented Providers (as of end of period)' at 5,324 . The estimate is in contrast to the year-ago figure of 4,789 .
The consensus among analysts is that 'Value-Based Care Attributed Lives (as of end of period)' will reach 1.42 million. The estimate is in contrast to the year-ago figure of 1.26 million.
View all Key Company Metrics for Privia Health here>>>
Shares of Privia Health have demonstrated returns of -5.8% over the past month compared to the Zacks S&P 500 composite's -0.3% change. With a Zacks Rank #3 (Hold), PRVA is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Privia Health Group, Inc. (PRVA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
